Daniel Wilson to Potassium
This is a "connection" page, showing publications Daniel Wilson has written about Potassium.
Connection Strength
0.252
-
Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes. Expert Rev Clin Pharmacol. 2022 May; 15(5):501-513.
Score: 0.178
-
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial. J Am Soc Nephrol. 2022 01; 33(1):225-237.
Score: 0.043
-
Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics. J Hypertens. 2017 05; 35 Suppl 1:S57-S63.
Score: 0.031